A3 adenosine receptors and mitogen-activated protein kinases in lung injury following in vivo reperfusion

@article{Matot2006A3AR,
  title={A3 adenosine receptors and mitogen-activated protein kinases in lung injury following in vivo reperfusion},
  author={I. Matot and C. Weiniger and E. Zeira and E. Galun and B. Joshi and K. Jacobson},
  journal={Critical Care},
  year={2006},
  volume={10},
  pages={R65 - R65}
}
IntroductionAlthough activation of A3 adenosine receptors attenuates reperfusion lung injury and associated apoptosis, the signaling pathway that mediates this protection remains unclear. Adenosine agonists activate mitogen-activated protein kinases, and these kinases have been implicated in ischemia/reperfusion injury; the purpose of this study was therefore to determine whether A3 adenosine receptor stimulation with reperfusion modulates expression of the different mitogen-activated protein… Expand
Adenosine receptors and inflammation.
TLDR
The potent effects of adenosine signaling on the regulation of inflammation suggest that targeting specificadenosine receptor activation or inactivation using selective agonists and antagonists could have important therapeutic implications in numerous diseases. Expand
A3 adenosine receptor agonist, CF102, protects against hepatic ischemia/reperfusion injury following partial hepatectomy.
TLDR
CF102 had a protective effect on the liver of Wistar rats subsequent to IR injury during hepatectomy, which may be due to an anti‑inflammatory and anti‑apoptotic effect mediated by the A3AR. Expand
Targeting of adenosine receptors in ischemia–reperfusion injury
TLDR
No therapies are currently available that specifically target IR injury; however, targeting of specific adenosine receptors may offer therapeutic strategies in this regard. Expand
Caspase Inhibition Via A3 Adenosine Receptors: A New Cardioprotective Mechanism Against Myocardial Infarction
TLDR
The molecular mechanisms associated with A3AR mediated cardioprotection indicating a role for the pro-survival signalling pathways that decrease caspase-3 activity are described and novel insight into the pharmacological effects of A3 ARs in ameliorating myocardial ischaemia/reperfusion injury is provided. Expand
Adenosine receptor targeting in health and disease
TLDR
An overview of the present knowledge regarding the role of these adenosine receptors in health and disease is provided and selective ligands for these receptors are likely to find applications in the treatment of pain, ischemic conditions, glaucoma, asthma, arthritis, cancer and other disorders in which inflammation is a feature. Expand
Adenosine receptors in health and disease.
TLDR
It can be speculated that adenosine A(1, A(2A), A( 2B), and A(3) receptor-selective ligands may show utility in the treatment of pain, ischemic conditions, glaucoma, asthma, arthritis, cancer, and other disorders in which inflammation is a feature. Expand
Adenosine receptor A3 is a critical mediator in LPS-induced pulmonary inflammation.
TLDR
The results shed new light on the role of A(3) in LPS-induced PMN trafficking in the lung and suggest pharmacological modulation of A (3)-dependent pathways as a promising approach in lung inflammation. Expand
The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-kappaB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats.
TLDR
Taken together, CF502 inhibits FLS growth and the inflammatory manifestations of arthritis, supporting the development of A(3)AR agonists for the treatment of rheumatoid arthritis. Expand
Intestinal ischemia-reperfusion injury alters purinergic receptor expression in clinically relevant extraintestinal organs.
TLDR
Purinoceptor expression is altered in the murine lung and kidney, but not intestine following experimental IIR injury, which may implicate extracellular nucleotides and purinoceptors as possible mediators of the extra-intestinal organ dysfunction associated with IIR injuries. Expand
The A3 adenosine receptor attenuates the calcium rise triggered by NMDA receptors in retinal ganglion cells
The A(3) adenosine receptor is emerging as an important regulator of neuronal signaling, and in some situations receptor stimulation can limit excitability. As the NMDA receptor frequentlyExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 70 REFERENCES
Activation of A3 Adenosine Receptors Attenuates Lung Injury after In Vivo Reperfusion
TLDR
In the feline lung, the A3AR agonist IB-MECA confers a powerful protection against IR lung injury and is mediated by a nitric oxide synthase–independent pathway and involves opening of adenosine triphosphate–sensitive potassium channels. Expand
Acute adenosine preconditioning is mediated by p38 MAPK activation in discrete subcellular compartments.
TLDR
A role for p38 MAPK activation in discrete subcellular compartments in acute adenosine A(1) receptor PC is suggested. Expand
A1 adenosine receptor antagonists block ischemia-reperfusion injury of the lung.
TLDR
Data support the hypothesis that A1 receptor antagonists block I-R injury of the lung and suggest that A2 receptor antagonists may be useful in preventing I- R injury after transplant surgery and during surgical procedures associated with I-r Injury of the heart, brain, kidney, and spinal cord. Expand
Delayed adenosine A1 receptor preconditioning in rat myocardium is MAPK dependent but iNOS independent.
TLDR
Results indicate that adenosine A1 receptor delayed PC in rats is mediated by MAPK-dependent mechanisms, but this phenomenon is not associated with the early or late expression of iNOS. Expand
Activation of A3 Adenosine Receptor Provides Lung Protection Against Ischemia‐Reperfusion Injury Associated with Reduction in Apoptosis
  • J. Rivo, E. Zeira, E. Galun, I. Matot
  • Medicine
  • American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • 2004
TLDR
Even when given after the onset of ischemia, the A3AR agonist IB‐MECA conferred a powerful protection against reperfusion lung injury, which was associated with decreased apoptosis, which suggests a potentially important role for A3 AR in lung IR injury. Expand
Characterization of ERK1/2 signalling pathways induced by adenosine receptor subtypes in newborn rat cardiomyocytes
TLDR
It is shown that ERK1/2 activation by adenosine in cardiomyocytes results from an additive stimulation of A1, A2A, and A3ARs, which involves Gi/o proteins, PKC, and tyrosine kinase for A1 and A2ARs and Gs and PKA for A3AARs. Expand
Effects of a p38 mitogen-activated protein kinase inhibitor as an additive to Euro-Collins solution on reperfusion injury in canine lung transplantation1
TLDR
Results suggest that inhibiting p38 MAPK activation may attenuate ischemia/reperfusion injury in lung transplantation and the addition of FR167653 to Euro-Collins solution improved lung graft viability associated with the inhibition of p38MAPK activation. Expand
Inhibition of c-Jun NH2-Terminal Kinase Activity Improves Ischemia/Reperfusion Injury in Rat Lungs
TLDR
In conclusion, JNK plays a pivotal role in mediating lung injury caused by I/R, and inhibition of JNK activity has potential as an effective therapeutic strategy for preventing I-R injury during lung transplantation. Expand
A physiological role of the adenosine A3 receptor: sustained cardioprotection.
  • B. Liang, K. Jacobson
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 1998
TLDR
The study indicates that cardiac adenosine A3 receptor mediates a sustained cardioprotective function and represents a new cardiac therapeutic target. Expand
Cyclooxygenase-2 does not mediate late preconditioning induced by activation of adenosine A1 or A3 receptors.
TLDR
The goal of this study was to determine whether the delayed cardioprotective effects of adenosine A1 or A3 receptors are mediated by cyclooxygenase-2 (COX-2), which is an obligatory mediator of ischemic PC. Expand
...
1
2
3
4
5
...